{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:55:05Z","timestamp":1791824105412,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020365","name":"National Foundation for the Centers for Disease Control and Prevention Inc","doi-asserted-by":"publisher","award":["CDC-RFA-CE-23\\u20130002"],"award-info":[{"award-number":["CDC-RFA-CE-23\\u20130002"]}],"id":[{"id":"10.13039\/100020365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.chroma.2025.466461","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:47:24Z","timestamp":1760222844000},"page":"466461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Simultaneous analysis of stimulants, opioids, gabapentin, xylazine, benzodiazepines, cannabinoids, and novel stimulants\/hallucinogens in human urine"],"prefix":"10.1016","volume":"1763","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9054-1235","authenticated-orcid":false,"given":"Zhong-Min","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunmi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurunthachalam","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6408","key":"10.1016\/j.chroma.2025.466461_bib0001","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"Jalal","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.chroma.2025.466461_bib0002","doi-asserted-by":"crossref","unstructured":"M.F. Garnett, A.M. Mini\u00f1o, Drug overdose deaths in the United States, 2003\u20132023, NCHS Data Brief, no 522, 2024, Available at: https:\/\/dx.doi.org\/10.15620\/cdc\/170565 (Accessed on June 30, 2025).","DOI":"10.15620\/cdc\/170565"},{"issue":"14","key":"10.1016\/j.chroma.2025.466461_bib0003","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1503\/cmaj.231339","article-title":"Opioid-related deaths between 2019 and 2021 across 9 Canadian provinces and territories","volume":"196","author":"Ledlie","year":"2024","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.chroma.2025.466461_bib0004","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1192\/j.eurpsy.2021.2219","article-title":"Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018","volume":"64","author":"Pierce","year":"2021","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.chroma.2025.466461_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103854","article-title":"Twenty-year trends in pharmaceutical fentanyl and illicit fentanyl deaths, Australia 2001-2021","volume":"109","author":"Roxburgh","year":"2022","journal-title":"Int. J. Drug Policy."},{"key":"10.1016\/j.chroma.2025.466461_bib0006","series-title":"HHS acting secretary declares public health emergency to address national opioid crisis","year":"2017"},{"key":"10.1016\/j.chroma.2025.466461_bib0007","article-title":"The continuous opioid death crisis in Canada: changing characteristics and implications for path options forward","volume":"19","author":"Fischer","year":"2023","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.chroma.2025.466461_bib0008","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019, MMWR","volume":"70","author":"Mattson","year":"2021","journal-title":"Morbidity Mortality Weekly Report"},{"issue":"2","key":"10.1016\/j.chroma.2025.466461_bib0009","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/14659891.2021.2019329","article-title":"Type of drug use and risky determinants associated with fatal overdose among people who use drugs: a meta-analysis","volume":"28","author":"Armoon","year":"2021","journal-title":"J. Subst. Use"},{"issue":"26","key":"10.1016\/j.chroma.2025.466461_bib0010","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1007\/s00216-017-0561-x","article-title":"Determination of 89 drugs and other micropollutants in unfiltered wastewater and freshwater by LC-MS\/MS: an alternative sample preparation approach","volume":"409","author":"Asimakopoulos","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"issue":"6","key":"10.1016\/j.chroma.2025.466461_bib0011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.15425","article-title":"Analysis of urine drug test results from substance use disorder rreatment practices and overdose mortality rates, 2013-2020","volume":"5","author":"Whitley","year":"2022","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.chroma.2025.466461_bib0012","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2018.02.034","article-title":"Monitoring opioid and benzodiazepine use and abuse: is oral fluid or urine the preferred specimen type?","volume":"481","author":"Petrides","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.chroma.2025.466461_bib0013","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1373\/clinchem.2019.305409","article-title":"Discovering cross-reactivity in urine drug screening immunoassays through large-scale analysis of electronic health records","volume":"65","author":"Hughey","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.chroma.2025.466461_bib0014","series-title":"HHS publication (SMA) 12-4668","article-title":"Substance abuse and mental health services administration; 2012. Technical assistance publication series TAP 32","year":"2012"},{"issue":"2","key":"10.1016\/j.chroma.2025.466461_bib0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"American pain society\u2013American academy of pain medicine opioids guidelines panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J. Pain."},{"issue":"2","key":"10.1016\/j.chroma.2025.466461_bib0016","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.36076\/ppj.2017.s92","article-title":"Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines","volume":"20","author":"Manchikanti","year":"2017","journal-title":"Pain. Physician"},{"issue":"3","key":"10.1016\/j.chroma.2025.466461_bib0017","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/ADM.0000000000000323","article-title":"Appropriate use of drug testing in clinical addiction medicine","volume":"11","author":"Jarvis","year":"2017","journal-title":"J. Addict. Med."},{"issue":"11","key":"10.1016\/j.chroma.2025.466461_bib0018","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/bmc.2945","article-title":"Rapid and simultaneous determination of multiple classes of abused drugs and metabolites in human urine by a robust LC-MS\/MS method - application to urine drug testing in pain clinics","volume":"27","author":"Wang","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"8","key":"10.1016\/j.chroma.2025.466461_bib0019","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/jat\/bks063","article-title":"Improved detection of opioid use in chronic pain patients through monitoring of opioid glucuronides in urine","volume":"36","author":"Dickerson","year":"2012","journal-title":"J. Anal. Toxicol."},{"issue":"15","key":"10.1016\/j.chroma.2025.466461_bib0020","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.clinbiochem.2009.07.019","article-title":"Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays","volume":"42","author":"Eichhorst","year":"2009","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.chroma.2025.466461_bib0021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/jat\/bkv024","article-title":"Simultaneous quantitation of 78 drugs and metabolites in urine with a dilute-and-shoot LC-MS-MS assay","volume":"39","author":"Cao","year":"2015","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.chroma.2025.466461_bib0022","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jat\/bkae004","article-title":"Evaluation of the Canadian approved drug screening equipment cut-off levels for tetrahydrocannabinol (THC)","volume":"48","author":"Copley","year":"2024","journal-title":"J. Anal. Toxicol."},{"issue":"6","key":"10.1016\/j.chroma.2025.466461_bib0023","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1373\/jalm.2018.027342","article-title":"A rapid dilute-and-shoot UPLC-MS\/MS assay to simultaneously measure 37 drugs and related metabolites in human urine for use in clinical pain management","volume":"3","author":"Dahlin","year":"2019","journal-title":"J. Appl. Lab. Med."},{"issue":"9","key":"10.1016\/j.chroma.2025.466461_bib0024","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2011\u20132016","volume":"67","author":"Hedegaard","year":"2018","journal-title":"NVSS"},{"issue":"32","key":"10.1016\/j.chroma.2025.466461_bib0025","doi-asserted-by":"crossref","first-page":"14169","DOI":"10.1021\/acs.est.4c05991","article-title":"Urinary and fecal excretion of 121 environmental chemicals in pet dogs and cats: significance of feces in biomonitoring of exposures","volume":"58","author":"Li","year":"2024","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.chroma.2025.466461_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108446","article-title":"An exposure assessment of 27 quaternary ammonium compounds in pet dogs and cats from New York State, USA","volume":"184","author":"Li","year":"2024","journal-title":"Environ. Int."},{"issue":"1","key":"10.1016\/j.chroma.2025.466461_bib0027","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/1047322X.1990.10389587","article-title":"Estimation of average concentration in the presence of nondetectable values","volume":"5","author":"Hornung","year":"1990","journal-title":"Appl. Occup. Environ. Hyg."},{"key":"10.1016\/j.chroma.2025.466461_bib0028","series-title":"R: A Language and Environment for Statistical Computing [Computer software]","year":"2023"},{"key":"10.1016\/j.chroma.2025.466461_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114607","article-title":"Assessment of licit and illicit drugs consumption during pregnancy by ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS) target screening in Mexican women hair","volume":"211","author":"Marchei","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2025.466461_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.461961","article-title":"Sample preparation and instrumental methods for illicit drugs in environmental and biological samples: A review","volume":"1640","author":"Chen","year":"2021","journal-title":"J. Chromatogr. A"},{"issue":"11","key":"10.1016\/j.chroma.2025.466461_bib0031","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/bmc.2945","article-title":"Rapid and simultaneous determination of multiple classes of abused drugs and metabolites in human urine by a robust LC-MS\/MS method\u2013application to urine drug testing in pain clinics","volume":"27","author":"Wang","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.chroma.2025.466461_bib0032","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00204-023-03631-z","article-title":"Quantification of 108 illicit drugs and metabolites in bile matrix by LC-MS\/MS for the toxicological testing of sudden death cases","volume":"98","author":"Franzin","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.chroma.2025.466461_bib0033","series-title":"Illicit drugs in the environment: occurrence, analysis, and fate using mass spectrometry","author":"Castiglioni","year":"2011"},{"issue":"8","key":"10.1016\/j.chroma.2025.466461_bib0034","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40261-015-0304-8","article-title":"Comparing gabapentin with clonazepam for residual sleeping problems following antidepressant therapy in patients with major depressive disorder: a randomized clinical trial","volume":"35","author":"Mowla","year":"2015","journal-title":"Clin. Drug Investig."},{"issue":"5","key":"10.1016\/j.chroma.2025.466461_bib0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MLR.0000000000000505","article-title":"A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain","volume":"54","author":"Bohnert","year":"2016","journal-title":"Med. Care"},{"issue":"1","key":"10.1016\/j.chroma.2025.466461_bib0036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/ors.12921","article-title":"Prevalence and clinical outcomes of off-label gabapentin prescription in neuropathic orofacial pain","volume":"18","author":"Tangpothitham","year":"2024","journal-title":"Oral Surg."},{"issue":"7","key":"10.1016\/j.chroma.2025.466461_bib0037","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jat\/24.7.467","article-title":"Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers","volume":"24","author":"Jufer","year":"2000","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.chroma.2025.466461_bib0038","article-title":"Cocaethylene: when cocaine and alcohol are taken together","volume":"14","author":"Pergolizzi","year":"2022","journal-title":"Cureus."},{"issue":"12","key":"10.1016\/j.chroma.2025.466461_bib0039","first-page":"1329","article-title":"Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psych"},{"issue":"1","key":"10.1016\/j.chroma.2025.466461_bib0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.23907\/2017.004","article-title":"Emerging synthetic fentanyl analogs","volume":"7","author":"Schueler","year":"2017","journal-title":"Acad. Forensic Pathol."},{"key":"10.1016\/j.chroma.2025.466461_bib0041","series-title":"Seminars in Neurology","first-page":"441","article-title":"Opioid maintenance therapy: A review of methadone, buprenorphine, and naltrexone treatments for opioid use disorder","author":"Fipps","year":"2024"},{"key":"10.1016\/j.chroma.2025.466461_bib0042","article-title":"Notes from the field: trends in gabapentin detection and involvement in drug overdose deaths\u201423 states and the District of Columbia, 2019\u20132020, MMWR","volume":"71","author":"Mattson","year":"2022","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"7","key":"10.1016\/j.chroma.2025.466461_bib0043","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.chroma.2025.466461_bib0044","first-page":"136","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psych"},{"issue":"8","key":"10.1016\/j.chroma.2025.466461_bib0045","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s11606-021-07035-6","article-title":"Benzodiazepine-involved overdose deaths in the USA: 2000-2019","volume":"37","author":"Kleinman","year":"2022","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.chroma.2025.466461_bib0046","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/ADM.0000000000000350","article-title":"A review of alprazolam use, misuse, and withdrawal","volume":"12","author":"Ait-Daoud","year":"2018","journal-title":"J. Addict. Med."},{"issue":"8","key":"10.1016\/j.chroma.2025.466461_bib0048","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and overdoses: trends, concerns, and recommendations","volume":"112","author":"Alexander","year":"2022","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.chroma.2025.466461_bib0049","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00406-024-01880-2","article-title":"Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits","volume":"275","author":"Hoch","year":"2025","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.chroma.2025.466461_bib0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj. Prev."},{"key":"10.1016\/j.chroma.2025.466461_bib0051","author":"Hedegaard"},{"issue":"11","key":"10.1016\/j.chroma.2025.466461_bib0052","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41386-023-01601-8","article-title":"Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis","volume":"48","author":"Butelman","year":"2023","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325008052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325008052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:52:50Z","timestamp":1773157970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967325008052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":51,"alternative-id":["S0021967325008052"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2025.466461","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous analysis of stimulants, opioids, gabapentin, xylazine, benzodiazepines, cannabinoids, and novel stimulants\/hallucinogens in human urine","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2025.466461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"466461"}}